Search results
Ipsen is a mid-sized global biopharmaceutical company that develops transformative medicines in oncology, rare disease and neuroscience. Learn about its strategy, culture, pipeline, partnerships, financial results and sustainability goals.
- Careers
Discover career opportunities at Ipsen and make a real...
- Français FR
Ipsen s’investit dans la sauvegarde et la préservation de...
- Partnering
Winner of Ipsen’s golden ticket announced as newest resident...
- Company
In 1983, the group created the Fondation Ipsen under the...
- Investors
We see everyone within the Ipsen investor community as a...
- Financial Results
Building on solid FY 2023 results, Ipsen anticipates four...
- Reports and Accounts
The Universal registration document is a summary document...
- Financial Calendar
Find information on Ipsen’s financial calendar, including...
- Careers
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.
Ipsen is a global biopharmaceutical company that offers career opportunities in various fields and locations. Learn about Ipsen's culture, values, benefits, and recruitment process, and explore Ipsen jobs that match your skills and passion.
Ipsen is a mid-sized company that develops and commercializes innovative medicines for people with high unmet medical needs. Learn about its strategy, news, therapeutic areas, patients, responsibility and careers.
Ipsen designs and manufactures industrial vacuum furnaces, atmosphere furnaces, and controls for thermal processing markets.
Ipsen is a global biopharmaceutical company that works with patients, their families and patient organizations to improve their lives and deliver outcomes that make a difference. Learn how Ipsen engages with patients, shares data and stories, and conducts clinical trials in its focus fields.
Ipsen is a public company that develops and markets medicines in oncology, rare disease and neuroscience. It has offices and employees in more than 40 countries and a pipeline fueled by external innovation.